scholarly article | Q13442814 |
P356 | DOI | 10.1128/AAC.1.2.148 |
P953 | full work available at URL | https://europepmc.org/articles/PMC444184 |
https://europepmc.org/articles/PMC444184?pdf=render | ||
https://journals.asm.org/doi/pdf/10.1128/AAC.1.2.148 | ||
P932 | PMC publication ID | 444184 |
P698 | PubMed publication ID | 4680804 |
P50 | author | John A. Washington | Q112429856 |
P2093 | author name string | M. Gardner | |
W. J. Martin | |||
P2860 | cites work | Antibacterial sensitivity of Bifidobacterium (Lactobacillus bifidus). | Q35146308 |
A study in vitro of the sensitivity to antibiotics of Bacteroides fragilis | Q36536135 | ||
The effect of carbon dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro | Q36556360 | ||
Antibiotic susceptibility patterns as aids in classification and characterization of gram-negative anaerobic bacilli. | Q40246945 | ||
Practical method for isolation of anerobic bacteria in the clinical laboratory | Q40711794 | ||
Simplified Method of Anaerobic Incubation | Q40716179 | ||
Bacteremic Bacteroides infections | Q43586845 | ||
The susceptibility of Clostridium perfringens type A to cephalosporin C antibiotics in vitro | Q44952369 | ||
Sensitivity of four species of bacteroides to antibiotics. | Q55500014 | ||
Antibiotic susceptibility of bacteroides species | Q69949452 | ||
Resistance of some strains ofBacteroides to ampicillin, methicillin and cloxacillin | Q71092430 | ||
Antibiotics for Bacteroides Sepsis | Q71791977 | ||
Lincomycin: activity against anaerobes and effect on normal human fecal flora | Q72704851 | ||
The susceptibility of bacteroides to the penicillins and cephalothin | Q72777158 | ||
Bacteroides in intra-abdominal sepsis: their sensitivity to antibiotics | Q74097800 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacology | Q128406 |
P304 | page(s) | 148-158 | |
P577 | publication date | 1972-02-01 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens | |
In Vitro Antimicrobial Susceptibility of Anaerobic Bacteria Isolated from Clinical Specimens | |||
P478 | volume | 1 |
Q45061200 | A Polycation Antimicrobial Peptide Mimic without Resistance Buildup against Propionibacterium Acnes |
Q67295266 | A note on the antibiotic susceptibilities ofClostridium perfringensserotypes isolated from meat |
Q67285976 | A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis |
Q35300876 | Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species |
Q40947562 | Aerobically incubated thioglycolate broth disk method for antibiotic susceptibility testing of anaerobes |
Q44565651 | Age-related frequency of penicillin resistance of oral Veillonella |
Q38851189 | Aminoglycosides: An Overview |
Q69354931 | Anaerobic Bacteria in Late Infections after Total Hip Arthroplasty |
Q70461127 | Anaerobic corneal ulcers |
Q54051608 | Anaerobic infections in the newborn infant. |
Q66843469 | Anaerobic infections of the female genital tract |
Q93751117 | Anaerobic infections of the female genital tract: Bacteriologic and therapeutic aspects |
Q39940660 | Anaerobic infections: a review |
Q39939580 | Antibiotic Susceptibility Testing of Anaerobic Bacteria by the Standardized Disc Diffusion Method with Special Reference to Bacteroides fragilis |
Q39954552 | Antibiotic Susceptibility of Clostridium Species Isolated from Human Infections |
Q40946132 | Antibiotic Susceptibility of the Subspecies of Bacteroides fragilis |
Q66979613 | Antibiotic lavage for peritonitis |
Q72940245 | Antibiotic resistance of anaerobic bacteria (author's transl) |
Q38508090 | Antibiotic resistance to Propionobacterium acnes: worldwide scenario, diagnosis and management. |
Q40482607 | Antibiotic sensitivity patterns of facultative and obligate anaerobic bacteria from pulp canals |
Q54494753 | Antibiotic susceptibility testing of subgingival plaque samples. |
Q36589768 | Antibiotic-disc tests for rapid identification of non-sporing anaerobes |
Q54468119 | Antimicrobial Properties of Gentamicin on the Skin |
Q33736915 | Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982 |
Q54359096 | Antimicrobial susceptibilities of Eubacterium, Peptostreptococcus, and Bacteroides isolated from root canals of teeth with periapical pathosis. |
Q54356265 | Antimicrobial susceptibilities of anaerobic bacteria isolated at the Mayo Clinic during 1982 through 1987: comparison with results from 1977 through 1981. |
Q35570414 | Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections |
Q35656719 | Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates |
Q40750977 | Antimicrobial susceptibility testing |
Q24562019 | Antimicrobiol susceptibility of Propinibacterium acnes and related microbial species |
Q43461557 | Bacteriology of empyema |
Q41028765 | Bacteriostatic and Bactericidal Activities of Various Antibiotics Against Bacteroides fragilis |
Q35761119 | Bacteroides fragilis resistance to clindamycin in vitro |
Q67441832 | Bacteroides fragilis resistant to the administration of clindamycin |
Q54786258 | Bacteroides infections. |
Q72540354 | Bacteroides melaninogenicus and dental infections: Some questions and some answers |
Q36458790 | Beta-Lactamase Activity in Strains of Bacteroides melaninogenicus and Bacteroides oralis |
Q35269353 | Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U |
Q54259559 | Beta-lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents |
Q54641278 | Beware — The Anaerobe Bandwagon |
Q39463764 | Bilateral abscessed orchiepididymitis associated with sepsis caused by Veillonella parvula and Clostridium perfringens: case report and review of the literature. |
Q54643598 | Biochemical Characterization and in vitro Determination of Antibiotic Susceptibility of Clinical Isolates of Bacteroides fragilis |
Q69356820 | Brain abscess |
Q89684194 | Case report: vertebral osteomyelitis secondary to a dental abscess |
Q36462251 | Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic |
Q41029005 | Cephalosporinase Activity in Bacteroides fragilis |
Q40890246 | Cerebrospinal fluid shunt infections with anaerobic diphtheroids (Propionibacterium species) |
Q36387568 | Characterization of pBFTM10, a clindamycin-erythromycin resistance transfer factor from Bacteroides fragilis. |
Q40616954 | Chemotherapy of an experimental Bacteroides fragilis infection in mice |
Q70220909 | Chloramphenicol |
Q37901029 | Chloramphenicol and tetracyclines. |
Q70220864 | Clindamycin |
Q35814755 | Clindamycin plus gentamicin as expectant therapy for presumed mixed infections |
Q33823463 | Clindamycin--efficacy and toxicity |
Q55254391 | Clinical importance of infections due to Bacteroides fragilis and role of antibiotic therapy. |
Q33948256 | Comparative Susceptibility of Anaerobic Bacteria to Minocycline, Doxycycline, and Tetracycline |
Q34558775 | Complete genome sequence of Veillonella parvula type strain (Te3) |
Q41029998 | Compound 64716, a New Synthetic Antibacterial Agent |
Q41261131 | Concentration of azidocillin, erythromycin, doxycycline and clindamycin in dental alveolar serum after single oral doses |
Q40943635 | Disk susceptibility testing of slow-growing anaerobic bacteria |
Q34930311 | Economical Agar Dilution Technique for Susceptibility Testing of Anaerobes |
Q36475771 | Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis |
Q54240619 | Effect of preoperative antibiotic regimen on development of infection after intestinal surgery: Prospective, randomized, double-blind study. |
Q67433911 | Effects of prophylactic antibiotics on colonic healing |
Q66908302 | Efficacy of Intravenous Clindamycin and Methicillin in Cram-positive Soft Tissue infections |
Q37904600 | Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1). |
Q70779599 | Excretion of clindamycin in bile in common duct obstruction |
Q34134239 | Extrachromosomal elements in a variety of strains representing the Bacteroides fragilis group of organisms |
Q39458060 | Fluorescent-antibody studies on selected strains of Bacteroides fragilis subspecies fragilis |
Q35669938 | Gingival crevicular fluid levels of clindamycin compared with its minimal inhibitory concentrations for periodontal bacteria |
Q71054934 | High-Dose Penicillin to Prevent Postoperative Wound Sepsis after Ileocolorectal Operations |
Q40946383 | Identification and antimicrobial susceptibility of 250 Bacteriodes fragilis subspecies tested by broth microdilution methods |
Q70735819 | Identification and susceptibility patterns of anaerobic bacteria isolated from clinical specimens during a one-year period |
Q34924648 | In vitro activity of penicillins against anaerobes |
Q40946546 | In vitro susceptibilities of anaerobic bacteria to josamycin |
Q40621227 | Inactivation of Cephalosporins by Bacteroides |
Q66929753 | Incidence and Significance of Intraperitoneal Anaerobic bacteria |
Q36652933 | Incidence and isolation of Bacteroides species from clinical material and their sensitivity to antibiotics |
Q36771179 | Indirect fluorescent antibody procedure for the rapid detection and identification of Bacteroides and Fusobacterium in clinical specimens |
Q39106263 | Influence of penicillinase production by strains of Bacteroides melaninogenicus and Bacteroides oralis on penicillin therapy of an experimental mixed anaerobic infection in mice |
Q43586619 | Influence of peroral antibiotics upon the biotransformatory activity of the intestinal microflora in healthy subjects |
Q36470130 | Isolation and Characterization of Multiply Antibiotic-Resistant Clostridium perfringens Strains from Porcine Feces |
Q54643072 | Lincomycin and clindamycin: their role in chemotherapy of anaerobic and microaerophilic infections. |
Q95720916 | Lincomycin-induced endotoxin release in Escherichia coli sepsis: evidence for release in vitro and in vivo |
Q40876031 | Management and microbiology of cutaneous abscesses |
Q37321049 | Medium for selective isolation of Fusobacterium nucleatum from human periodontal pockets |
Q40123009 | Methods for testing antibiotic sensitivity of anaerobic bacteria |
Q40943987 | Microdilution Technique for Antimicrobial Susceptibility Testing of Anaerobic Bacteria |
Q42929532 | Minimal inhibitory concentrations of various antimicrobial agents for human oral anaerobic bacteria |
Q35877334 | Newer Antibacterial and Antimycotic Drugs: Critical Appraisal |
Q35005078 | Non-vertebral Veillonella species septicemia and osteomyelitis in a patient with diabetes: a case report and review of the literature |
Q40228618 | Obligate anaerobes in clinical veterinary practice |
Q35574108 | Occurrence of clindamycin-resistant anaerobic bacteria isolated from cultures taken following clindamycin therapy |
Q36714731 | Penetration into bone and tissues of clindamycin phosphate |
Q36431260 | Penicillin Resistance and Penicillinase Production in Clinical Isolates of Bacteroides melaninogenicus |
Q68962456 | Pharmacokinetic Studies of Clindamycin Phosphate |
Q39212200 | Pleuropulmonary lung infection by anaerobic bacteria |
Q33728043 | Practical anaerobic broth-disk elution susceptibility test |
Q40943124 | Proposed standardized method for testing and interpreting susceptibility of Bacteroides fragilis to tetracycline |
Q35343594 | Purification and characterization of a new beta-lactamase from Clostridium butyricum |
Q39999780 | Rapid Microbiological Assay for Chloramphenicol and Tetracyclines |
Q40236214 | Rapid identification of Bacteroides fragilis with bile and antibiotic disks |
Q34684086 | Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment |
Q35646492 | Resistance of Some Species of Clostridium to Clindamycin |
Q64239773 | Sensitivity to Oxygen in Microbial Electrochemical Systems Biofilms |
Q41030426 | Speed of bactericidal action of penicillin G, ampicillin, and carbenicillin on Bacteroides fragilis |
Q39974051 | Stability in Escherichia coli of an antibiotic resistance plasmid from Bacteroides fragilis |
Q41028311 | Standardized antimicrobial disc susceptibility testing of anaerobic bacteria: in vitro susceptibility of Clostridium perfringens to nine antibiotics |
Q40943790 | Susceptibility of Anaerobes to Cefoxitin and Other Cephalosporins |
Q41028799 | Susceptibility of Bacteroides fragilis to Six Antibiotics Determined by Standardized Antimicrobial Disc Susceptibility Testing |
Q36462036 | Susceptibility of Clostridium perfringens Isolated from Human Infections to Twenty Antibiotics |
Q40943384 | Susceptibility of Clostridium ramosum to antimicrobial agents |
Q24600683 | Susceptibility of Propionibacterium acnes to seventeen antibiotics |
Q40947577 | Susceptibility of anaerobic bacteria to 23 antimicrobial agents |
Q40943236 | Susceptibility of anaerobic bacteria to carbenicillin |
Q36463129 | Susceptibility of anaerobic bacteria to cofoxitin and related compounds |
Q40617130 | Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods |
Q36473701 | Susceptibility of anaerobic bacteria to ten antimicrobial agents |
Q35740380 | Susceptibility of the Bacteroides fragilis group in the United States in 1981. |
Q40946875 | Susceptibility testing of anaerobic bacteria with 100-microg carbenicillin disks |
Q40355354 | Susceptibility to beta-lactam antibiotics and production of beta-lactamase inBacteroides fragilis |
Q35319269 | Tetracycline resistance and TetM in oral anaerobic bacteria and Neisseria perflava-N. sicca |
Q36754654 | Tetracycline resistance in Peptostreptococcus species |
Q39983803 | Tetracycline-inducible transfer of tetracycline resistance in Bacteroides fragilis in the absence of detectable plasmid DNA. |
Q37901091 | Tetracyclines, chloramphenicol, erythromycin, and clindamycin |
Q48648392 | The Importance of Anaerobic Bacteria in Infectious Diseases |
Q41219328 | The Microbiology of Paranasal Sinus Infections: Diagnosis and Management |
Q39927542 | The Newer Antibiotics |
Q54591610 | The bacteriology of aspiration pneumonia |
Q40633736 | The effect of metronidazole on the development of plaque and gingivitis in the beagle dog |
Q33655748 | The possible role of anaerobic bacteria in the aetiology of non-gonococcal urethritis in men |
Q28363600 | Treatment of Bacteroides infection with clindamycin-2-phosphate |
Q40943057 | Treatment of anaerobic bacterial infections with clindamycin-2-phosphate |
Q40944352 | Treatment of anaerobic infections with metronidazole |
Q41474933 | Treatment of obstetric and gynecologic infections with cefamandole |
Q35927153 | Treatment of severe bacteroides infections with parenteral clindamycin |
Q37239943 | Tryptic Soy Bile-Kanamycin Test for the Identification of Bacteroides fragilis |
Q39960611 | Unique Bactericidal Action of Metronidazole Against Bacteroides fragilis and Clostridium perfringens |
Q34052607 | Veillonella parvula meningitis: case report and review of Veillonella infections |
Search more.